Atlas Venture Associates Opportunity I, LLC's Net Worth

$481 Million

Estimate Recalculated Feb 23, 2024 07:02PM EST

Who is Atlas Venture Associates Opportunity I, LLC?

Atlas Venture Associates Opportunity I, LLC has an estimated net worth of $481 Million. This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., Day One Biopharmaceuticals, Inc., Dyne Therapeutics, Inc., Generation Bio Co., Akero Therapeutics, Inc., Replimune Group, Inc., Ikena Oncology, Inc., Kymera Therapeutics, Inc., Magenta Therapeutics, Inc., Disc Medicine, Inc., Xilio Therapeutics, Inc., AVROBIO, Inc., and Third Harmonic Bio, Inc..

SEC CIK

Atlas Venture Associates Opportunity I, LLC's CIK is 0001780066

Past Insider Trading and Trends

2022 was Atlas Venture Associates Opportunity I, LLC's most active year for acquiring shares with 10 total transactions. Atlas Venture Associates Opportunity I, LLC's most active month to acquire stocks was the month of May. 2021 was Atlas Venture Associates Opportunity I, LLC's most active year for disposing of shares, totalling 38 transactions. Atlas Venture Associates Opportunity I, LLC's most active month to dispose stocks was the month of November. 2022 saw Atlas Venture Associates Opportunity I, LLC paying a total of $34,090,021.70 for 16,180,239 shares, this is the most they've acquired in one year. In 2023 Atlas Venture Associates Opportunity I, LLC cashed out on 675,637 shares for a total of $34,351,525.03, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $15.83

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
766.67K
$15.00
$11,500,005.00
766.67K
Jun 17
Form 4
9M
$16.00
$8,000,000.00
9M
Feb 1 - Jun 1
Form 3
0
0
No matching records found

Dyne Therapeutics, Inc. (DYN) Snapshot price: $21.5

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-5.35%
-500.79K
$22.68
-$11,339,780.44
8.86M
Scheduled
Feb 21 - Feb 23
Form 4
934.58K
$10.70
$10,000,016.70
934.58K
Dec 12
Form 4
+361.95%
7.64M
9.75M
Sep 21
Form 3
0
0
No matching records found

Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.88

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
3.97M
$16.00
3.97M
Jun 24
Form 3
0
0
No matching records found

Ikena Oncology, Inc. (IKNA) Snapshot price: $1.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.89%
98.72K
$15.34
$1,614,428.13
2.12M
Mar 30 - Dec 14
Form 4
+2,809.29%
4.75M
4.92M
Mar 30
Form 3
0
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.6453

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.04%
-1.00K
$0.64
-$640.00
2.75M
Feb 8
Form 4
-0.15%
-4.24K
$0.85
-$3,600.45
2.76M
Jan 11 - Jan 12
Form 3
0
0
No matching records found